NEW YORK, Jan 25 (Reuters) – Pfizer Inc. and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target…
Read More
NEW YORK, Jan 25 (Reuters) – Pfizer Inc. and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target…
Read More
(Reuters) – BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that…
Read More
Nov 22 (Reuters) – Pfizer Inc. said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15…
Read More
(AP) – Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key…
Read More
NEW YORK (Reuters) – Drug makers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID–19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts…
Read More
Hong Kong, China (AFP) – People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing…
Read More
Despite being the most talked about and sought-after vaccine in Thailand, not a single dose of Pfizer-BioNTech has been administered here to date. The Pfizer jab’s efficacy is impressively high…
Read More
Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of…
Read More
Pfizer/BioNTech said Friday they have asked European regulators to authorize their Covid-19 vaccine for 12- to 15-year-olds, a move seen as a crucial step toward achieving herd immunity. The companies…
Read MorePage 1 of 1